News

Exploring the complexities of assisted dying, ethical dilemmas, and the evolving role of physicians in end-of-life decisions.

EmPATH units revolutionize emergency psychiatry, offering rapid, compassionate care for behavioral health crises and improving community outcomes.

Transneural Therapeutics launches innovative neuroplastogens to revolutionize treatment for neuropsychiatric diseases, promising safer, effective alternatives to psychedelics.

The debate on physician-assisted suicide challenges medical ethics, emphasizing the role of doctors in providing care, not death, while navigating societal pressures.

Cobenfy as an adjunctive treatment to atypical antipsychotics did not reach the primary endpoint of the phase 3 ARISE trial, or a statistically significant difference compared with placebo with an atypical antipsychotic.

Emergency departments face unique challenges in providing psychiatric care for individuals with intellectual and developmental disabilities, impacting wait times and overall experience.

Cybin partners with Osmind to enhance mental health treatment access, focusing on innovative therapies for depression and anxiety disorders.

Happy Earth Day! What terms should we be using to describe our current climate situation? Let’s decide.

A recent study reveals some alarming statistics about physician suicide. What interventions can help reduce this trend?

The first patient has been dosed in MindMed’s phase 3 Emerge study evaluating the efficacy of MM120 ODT.

2025: one of the most consequential years ever for emergency psychiatry.

The use of arts in psychiatry has been a healing and therapeutic tool of care, though unfortunately decimated over the years by cuts in funding.

Explore key updates in psychiatric health, including Black maternal health, self-harm insights, schizophrenia treatment advancements, and expert interviews.

About 40% of women who have postpartum depression go unrecognized and untreated, and they are still symptomatic 3 years later.

A retired psychiatrist has a conversation with AI about substance use disorder treatment.

At this time of great importance for religion, we see an increase in political anxiety.

The Lancet Commission report on nonfatal self-harm identifies key challenges, causes, and more.

A pioneer in cognitive behavior therapy shares his thoughts on a 50-year-long career.

The arson attack on Pennsylvania Governor Shapiro might have happened for a number of reasons…

"Tell him I’m sorry I still owe him money..."

New research reveals that discontinuing long-term benzodiazepine therapy may increase risks of mortality and other adverse outcomes, challenging common assumptions.

Dr Wilsa Charles Malveaux highlights the urgent need to address mental health in Black Maternal Health Week, especially for Black mothers and athletes.

How can psychiatric professionals and pharmacists best work together to improve patient care? One pharmacist shares his thoughts.

Take a look at the differentiation between prodrome and attenuated psychosis, along with cognitive impairment associated with schizophrenia.

The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) for treatment-resistant major depressive disorder has now demonstrated promise for reducing depressive symptoms of bipolar I disorder in an open-label feasibility and safety trial.

Professionally and personally, what do you think about choosing your own death?

What new possibilities for unification can emerge?

Truth is a collective verdict in the slow cooker of time, not an individual alloy smelted in the crucible of the moment.